Telogen Effluvium – A Complete Patient‑Friendly Guide
Overview
Telogen effluvium (TE) is a common, usually reversible form of diffuse hair shedding that occurs when a larger‑than‑normal number of hair follicles enter the telogen (resting) phase of the hair growth cycle. Instead of shedding 5‑10 % of scalp hairs per month (the normal rate), people with TE may lose 30‑50 % of their hairs over several weeks to months.
TE can affect anyone, but it is most frequently observed in:
- Women aged 25‑55 (approximately 70 % of cases)
- Men of similar age groups, especially after acute illness or surgery
- Individuals undergoing major physiological stress (e.g., postpartum period)
According to the American Academy of Dermatology, TE accounts for 30‑40 % of all hair‑loss consultations in dermatology clinics worldwide, making it one of the leading causes of diffuse alopecia.1
Symptoms
Telogen effluvium is characterized by a constellation of signs that develop gradually (often 2‑3 months after the triggering event) and may persist for up to 6 months or longer in chronic cases.
Primary symptoms
- Excessive shedding: Noticeable strands of hair on the pillow, in the shower, or when brushing.
- Diffuse thinning: Hair appears less dense across the entire scalp rather than in distinct patches.
- Positive hair‑pull test: Gently pulling a small bundle (≈40 hairs) yields >10 % loose hairs.
Associated symptoms
- Mild scalp itching or tightness (usually secondary to stress, not inflammation).
- Feelings of anxiety or self‑consciousness about appearance.
- If TE is secondary to an underlying condition, symptoms of that condition may be present (e.g., fever, weight change, menstrual irregularities).
Causes and Risk Factors
Telogen effluvium is a reaction to a physical or emotional stressor that disrupts the normal hair‑growth cycle. The trigger pushes many follicles prematurely from the anagen (growth) phase into the telogen phase.
Common precipitants
- Systemic illness or fever: Influenza, COVID‑19, severe bacterial infections, or hospitalization.
- Surgical procedures: Especially major operations with significant blood loss or anesthesia.
- Medications: Anticoagulants, retinoids, β‑blockers, antiretrovirals, and certain antidepressants.
- Hormonal changes: Pregnancy, postpartum period, abrupt discontinuation of oral contraceptives, thyroid disorders.
- Severe emotional stress: Bereavement, job loss, or major life changes.
- Nutrition deficiencies: Iron, zinc, biotin, protein, or severe caloric restriction (e.g., eating disorders, crash diets).
- Chronic illness: Autoimmune disease (lupus, rheumatoid arthritis), chronic kidney disease, or malignancy.
Risk factors that increase susceptibility
- Female sex (due to higher prevalence of hormonal fluctuations and iron deficiency)
- Age 30‑50 (peak of reproductive‑hormone changes)
- Pre‑existing mild alopecia (e.g., androgenetic alopecia) – TE may accentuate thinning.
- Genetic predisposition to faster follicular cycling.
- Smoking and excessive alcohol intake, which can impair microcirculation to the scalp.
Diagnosis
Diagnosing TE is primarily clinical, based on history, physical exam, and exclusion of other hair‑loss disorders.
Step‑by‑step diagnostic approach
- Detailed history: Onset, recent illnesses, surgeries, medication changes, diet, stressors, and menstrual or pregnancy history.
- Physical examination: Scalp inspection for diffuse thinning without scarring; perform a hair‑pull test.
- Trichogram or phototrichogram: Microscopic evaluation of a shaved 1‑cm² area to determine the proportion of hairs in telogen (normally <10 %). In TE, telogen hairs may rise to 30‑40 %.
- Blood work (when indicated):
- Complete blood count (CBC) – rule out anemia.
- Thyroid‑stimulating hormone (TSH) – detect hypo‑ or hyperthyroidism.
- Serum ferritin and iron studies – iron deficiency is a frequent co‑factor.
- Zinc, vitamin D, and vitamin B12 levels if nutritional deficiency is suspected.
- Scalp biopsy (rare): Reserved for atypical cases where scarring alopecia or other dermatologic conditions cannot be excluded.
Differential diagnosis
- Androgenetic alopecia (pattern hair loss)
- Alopecia areata (patchy, autoimmune)
- Scarring (cicatricial) alopecia
- Drug‑induced alopecia (e.g., chemotherapy)
- Fungal infections (tinea capitis)
Treatment Options
Since TE is usually self‑limited, treatment focuses on identifying and correcting the underlying trigger, supporting follicular recovery, and minimizing further shedding.
Address the root cause
- Medical conditions: Treat thyroid disease, iron‑deficiency anemia, or chronic infections.
- Medication review: Discuss with a prescriber whether a suspected drug can be switched or tapered.
- Stress management: Cognitive‑behavioral therapy (CBT), mindfulness, or counseling.
Pharmacologic & topical options
- Iron supplementation: Oral ferrous sulfate 325 mg (65 mg elemental iron) daily if ferritin <30 ng/mL. Monitor for GI side effects.
- Multivitamin/mineral complexes: Containing zinc, biotin, and vitamin D for borderline deficiencies.
- Topical minoxidil 2 % (women) or 5 % (men): May accelerate the shift from telogen to anagen and shorten shedding time. Use twice daily, with caution in patients with cardiovascular disease.
- Low‑dose oral finasteride (1 mg) or dutasteride: Only in men with concurrent androgenetic alopecia; not a primary therapy for TE.
Procedural & supportive measures
- Low‑level laser therapy (LLLT): FDA‑cleared devices can improve hair density in some studies, though evidence for acute TE is limited.
- Platelet‑rich plasma (PRP): Investigational for chronic TE; may be considered in specialty clinics.
- Scalp massage & gentle hair care: Reduces mechanical trauma and may increase local blood flow.
Lifestyle & self‑care recommendations
- Adopt a balanced diet rich in protein, leafy greens, nuts, and fish.
- Limit heat styling, tight hairstyles, and harsh chemical treatments.
- Stay hydrated; aim for ≥2 L water per day.
- Sleep 7‑9 hours nightly to support hormonal balance.
Living with Telogen Effluvium
While TE can be distressing, most people experience regrowth within 6‑12 months once the trigger resolves. Below are practical tips for daily management.
- Gentle hair handling: Use a wide‑tooth comb, avoid vigorous towel‑drying, and limit brushing to once or twice a day.
- Volumizing hairstyles: Layered cuts, short bobs, or textured pixie cuts create the illusion of thickness.
- Hair‑care products: Choose sulfate‑free shampoos, lightweight conditioners, and avoid heavy styling gels.
- Stress‑reduction routine: 10‑minute mindfulness breathing exercise each morning; consider yoga or Tai Chi.
- Track shedding: Take weekly photos and keep a simple log of shedding severity; this helps reassure you and provides data for your clinician.
- Support network: Join online forums (e.g., American Hair Loss Association) or local support groups to share experiences.
Prevention
Because TE is usually triggered by an acute stressor, complete prevention is not always possible. However, minimizing known risk factors can reduce the likelihood of an episode.
- Maintain adequate iron stores (serum ferritin >30 ng/mL) especially in menstruating women.
- Follow a nutritionally balanced diet; consider a prenatal‑type multivitamin if diet is insufficient.
- Manage chronic illnesses proactively (e.g., keep thyroid function stable).
- Avoid crash dieting; aim for slow, sustainable weight loss (≤0.5 kg/week).
- Schedule elective surgeries after discussing hair‑loss risk with your surgeon; request peri‑operative nutritional support if needed.
- Practice regular stress‑management techniques—consistent exercise, adequate sleep, and relaxation practices.
Complications
Although TE is benign, untreated or unrecognized underlying causes can lead to secondary problems:
- Psychological impact: Persistent hair loss can cause anxiety, depression, or reduced self‑esteem.
- Conversion to chronic telogen effluvium: In roughly 5‑10 % of cases, TE persists beyond 12 months and becomes “chronic TE,” often linked to ongoing nutritional deficits or autoimmune disease.
- Exacerbation of concomitant alopecia: Individuals with androgenetic alopecia may notice accelerated thinning.
- Scarring alopecia: Rare, but if an inflammatory condition is misdiagnosed as TE, permanent hair loss may develop.
When to Seek Emergency Care
Call emergency services (9‑1‑1) or go to the nearest emergency department if you notice any of the following:
- Sudden, rapid hair loss accompanied by high fever, severe headache, stiff neck, or confusion (possible meningitis or severe infection).
- Profuse bleeding from the scalp after minimal trauma.
- Signs of an acute allergic reaction to a new medication (difficulty breathing, swelling of lips or throat, hives) that coincides with hair shedding.
- Severe chest pain, palpitations, or shortness of breath after starting a medication noted to cause TE.
These symptoms are not typical of telogen effluvium itself but may indicate a medical emergency that requires immediate attention.
Key Take‑aways
- Telogen effluvium is a reversible, diffuse hair‑shedding condition most often triggered by physiological or emotional stress.
- Diagnosis is clinical; blood tests rule out anemia, thyroid disease, and nutritional deficiencies.
- Treatment centers on removing the trigger, correcting deficiencies (especially iron), and using supportive measures such as minoxidil or gentle hair‑care practices.
- Most patients experience regrowth within 6‑12 months, but chronic cases can persist and merit specialist follow‑up.
- Seek urgent care only if hair loss is accompanied by systemic warning signs (fever, severe pain, allergic reaction).
References:
- American Academy of Dermatology. Telogen Effluvium Clinical Guidelines. 2023.
- Mayo Clinic. “Telogen effluvium.” Accessed June 2026.
- National Institutes of Health, Office of Dietary Supplements. “Iron and Hair Loss.” 2022.
- Centers for Disease Control and Prevention. “Stress and Physical Health.” 2021.
- Cleveland Clinic. “Hair loss: Diagnosis and treatment.” 2024.
- World Health Organization. “Guidelines for the management of anemia.” 2020.